Posted Aug 20, 2026

General Manager

Apply Now

Job Title: General Manager

Location: India – remote Position

Why Join us Now

Radiopharmaceutical are redefining cancer treatment and actinium pharmaceuticals (NYSE:ATNM) is at the forefront. We are building first-in-class targeted radiotherapies by combining deep radiochemistry expertise with cancer biology insight, creating platform-level opportunities across solid tumors and hematologic malignancies.

The Opportunity

The General Manager will build and lead Actinium’s India platform at a pivotal moment in radiopharmaceutical innovation. This role owns the end-to-end strategy and execution across manufacturing, clinical development, and regulatory engagement transforming India into a core drive of Actinium’s global oncology pipeline. This is a hands-on, high impact leadership role for someone excited to build, influence, and deliver shaping how Actinium advances targeted alpha therapies from clinical promise to real-world impact.

Your Impact

Country Strategy & Platform Build

Manufacturing, Supply Chain & CMC Leadership

Clinical Development & Hospital Alliances

Regulatory Strategy & Compliance

Operational, Financial & Organizational Leadership

Risk Management & Execution Excellence

What you Need

Actinium is an equal opportunity employer. It is our policy and practice to employ, promote, and otherwise treat all employees and applicants on the basis of merit, qualifications, and competence. The company’s policy prohibits unlawful discrimination, including but not limited to, discrimination on the basis of protected Veterans status, individuals with disabilities status, and consistent with all federal, state or local laws.

Advanced scientific or health-related degree, senior biotech leadership, oncology trial leadership, Indian regulatory expertise, strategic partnership experience, and strong analytical, communication, and negotiation skills.

Key Responsibilities

Skills & Tools

GCP, ICH, CDSCO, DCGI, CTRI, CAPA

Job Details

About Actinium Pharmaceuticals, Inc.

A biopharmaceutical company developing targeted alpha therapies for cancer treatment. — Industry: Healthcare